Harry Perkins Institute of Medical Research

We're gearing up for our biggest fundraising event of the year - the MACA Cancer 200 Ride for the Perkins - this weekend. Congratulations to all the Riders and their supporters, who have tipped us over the $8M mark, with a week to go before nearly 2000 Riders don their lycra and hit the road to raise funds for life-changing cancer research at the Perkins. And spare an extra thought for Peter Firth and his Froth Craft Brewery Team, three of whom will be riding the 200km to Mandurah and back on their penny farthings... You can read more about their personal reasons for this monumental effort in this article from PerthNow Local Newspapers. And if you're out and about between Perth and Mandurah this weekend, keep an eye out for the MACA Cancer 200 Ride for the Perkins fleet and show them your support. https://lnkd.in/gj5FpcPj

We are delighted to announce this year's Wesfarmers Harry Perkins Oration guest is Joint 2024 Australian of the Year, Professor Richard Scolyer, AO. Prof Scolyer's topic: Beating Cancer—A Melanoma Researcher Who Becomes a Brain Cancer Patient! As Co-Medical Director of Melanoma Institute Australia, Prof Scolyer is at the forefront of tackling “Australia’s National Cancer”, melanoma, the devastating price we pay for living in the sunburnt country.   Prof Scolyer’s life changed in June 2023 when he was diagnosed with an aggressive, incurable form of brain cancer. He underwent world-first experimental treatment based on melanoma science, devised by his colleague and fellow Australian of the Year Professor Georgina Long AO. Prof Scolyer’s scan in July showed no sign of cancer recurrence. Could this world-first experimental treatment change the outlook for brain cancer? Please join us for this very special event, and Prof Scolyer's last appearance in Perth as Australian of the Year. Tickets are free, but bookings are essential. Follow the link below. #AustralianoftheYear #melanoma #braincancer #glioblastoma #immunotherapy #cancer

We're #hiring a new Corporate Partnerships Manager in Nedlands, Western Australia. Apply today or share this post with your network.

The Perkins Community Engagement Team is hiring - we're on the lookout for a Corporate Partnerships Manager to help grow the impact of corporate relationships for our three major fundraising events, the MACA Cancer 200 Ride for the Perkins, New Town Toyota Walk For Women's Cancer and the Perkins Plunge powered by Mineral Resources Limited. If you're a proven business development professional who thrives on ambitious goals and can align our strategy with our partners' objectives, we want to hear from you. Check out the job posting and get in touch! https://lnkd.in/de_qMVFq

A Friday vibe to kick off the long weekend in WA. What better time to dust off the Hula Hoop and get a few practise swings in for Hula 4 Heart - a fun challenge to raise funds to support #cardiovascular research to help save the life we lose every 12 minutes to heart-related disease. Our thanks to Kate Kirwin, our 2024 Hula 4 Heart Ambassador, 2024 WA Young Australian of the Year, founder of She Codes Australia, and strong advocate for women in STEM, for sharing her Hula passion and advice! We're challenging you to Hula 12 mins a day for 31 days, starting this #WorldHeartDay, 29 Sep. Sign up at the link, raise your first $100 and we'll send you a FREE smart weighted Hula to get you going!

Congratulations to Professor Ruth Ganss on the publication of her latest research into the Cancer Microenvironment, published in The Journal of Clinical Investigation today. Prof Ganss's paper, titled "Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models" showed that when the dose of anti-cancer drugs was considerably reduced, the tumour initially grew, but then the blood vessels surrounding the tumour normalised, allowing immunotherapy to penetrate the tumour and be more effective. “My team and I are excited to have found new ways of modulating cancer blood vessels with already clinically approved drugs, and now we can hopefully produce an outcome which lends itself to better, more effective treatments for the very sick and prolonging their lives.” Read more here: https://lnkd.in/gXHTPCem IMAGES: 1. Prof Ruth Ganss 2. Normalized tumour blood vessel following low dose trametinib treatment. Yellow (staining for activation marker ICAM/green) indicates activation of tumour blood vessel (red) to enable immune cell access into tumour. 3. Abnormal tumour blood vessel (red), no substantial activation (yellow). #cancerresearch #cancer #pancreaticcancer #melanoma #braincancer #cancermicroenvironment #immunotherapy #medicalresearch

The Perkins is hiring. We have two Executive level positions on offer, through our recruitment partner, Derwent. New Position: Deputy Director We are embarking on a strategic and cultural transformation journey and the position of Deputy Director is critical to our success. This new position will be responsible for significant leadership and strategic deliverables across research programs, research development and research integrity. More information here: https://lnkd.in/gttdY-vj Chief Operations Officer As the Chief Operations Officer, you will play a crucial role in leading the strategic execution of Perkins’ operational services, ensuring their world-class research facilities and services operate efficiently, safely, and sustainably. Reporting directly to the CEO, you will oversee multiple key areas, including Facilities Management, ICT, Research Operations, and more, while fostering a cohesive, high-performing organisational culture. More information here: https://lnkd.in/gC-q5zn5 Please share with your networks. Applications close 27 September 2024 #executiveroles #csuiterecruitment #medicalresearch #recruitment

We were delighted to welcome members of The CEO Institute WA to the Perkins this week, for a special event, Curiosity: A conversation - Science Innovation meets Business Acumen. CEO Institute members and guests enjoyed networking before six Perkins researchers specialising in cancer, cardiovascular disease, genetics and genomics presented brief overviews of the ground-breaking discoveries they're making to tackle the world's toughest diseases.   It was also a perfect opportunity to introduce Perkins Partners, our dynamic corporate partnerships initiative. This program places WA businesses at the forefront of groundbreaking discoveries, offering an unparalleled opportunity to collaborate and drive tangible change in the health of our community through supporting WA's best medical researchers. Thank you to the CEO Institute of WA, members and guests, and of course, our panel of researchers, for sharing their knowledge, ideas and inspiration. You can find out more about Perkins Partners here: https://lnkd.in/g4JeY9dF #Innovation #collaboration #corporateevents #corporatepartnerships #corporatesponsors #membership #medicalresearch The CEO Institute WA | Harry Perkins Institute of Medical Research | Steve Stanley | Prof Peter Leedman | Julie Rene | Darroné Manning | Celia Byatt Theodore Wai Ng

Congratulations A/Prof Gina Ravenscroft, Mid-Career Scientist of the Year, and Nicola Principe, Student Scientist of the Year at the Premier's Science Awards 2024! And congratulations to Dr Kieran Mulroney for being named a Finalist in the Early-Career Scientist of the Year category. Very proud to have you all as part of the Perkins family, striving for longer, healthier and better lives. #WASciAwards #FutureJobsFutureSkills #ScienceWeek #STEM #WesternAustralia

Tonight's the night! The Premier's Science Awards for 2024 will be announced and we want to wish these outstanding finalists from the Harry Perkins Institute of Medical Research, A/Prof Gina Ravenscroft (Mid-career Scientist of the Year), Dr Kieran Mulroney (Early-career Scientist of the Year) and Nicola Principe (Student Scientist of the Year) all the very best in their respective categories. #WASciAwards #FutureJobsFutureSkills #ScienceWeek #STEM #WesternAustralia